GIA
ELV icon

Guyasuta Investment Advisors’s Elevance Health ELV Stock Holding History

Guyasuta Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-420
Closed -$218K – 270
2024
Q3 		$218K Buy
+420
New +$224K 0.01% 256
2023
Q2 		– Sell
-492
Closed -$226K – 245
2023
Q1 		$226K Hold
492
– – 0.02% 229
2022
Q4 		$252K Buy
492
+30
+6% +$15.2K 0.02% 205
2022
Q3 		$210K Hold
462
– – 0.02% 213
2022
Q2 		$223K Buy
+462
New +$229K 0.02% 242

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Guyasuta Investment Advisors's ELV Position: Q4 2024 in Review

Guyasuta Investment Advisors sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 420 shares — an estimated $218K sold.

Guyasuta Investment Advisors first reported a position in ELV in Q2 2022 and held it in 5 quarters. The position peaked at $252K in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Guyasuta Investment Advisors reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Guyasuta Investment Advisors sold 420 Elevance Health shares in Q4 2024, an estimated $218K.
  • Guyasuta Investment Advisors first reported a position in Elevance Health in Q2 2022 and held it in 5 quarters.
  • Guyasuta Investment Advisors's Elevance Health position peaked at $252K in Q4 2022.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Guyasuta Investment Advisors's 13F filing for Q4 2024, filed 30 Jan 2025.